Samuel Goldman, MD, MPH

Title(s)Professor, Medicine
SchoolSchool of Medicine
AddressRemote Location
Varies 00001
Phone--
Emailsamuel.goldman@ucsf.edu
ORCID ORCID Icon0000-0002-3039-9927 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Michigan, Ann Arbor, MIBS08/1982Psychology
    University of Texas, Houston, Houston, TXMD05/1987Medicine
    Mt. Zion Hospital, San Francisco, CA06/1988Internal Medicine
    University of California-Berkeley, Berkeley, CAMPH05/1993Environmental Health Science
    University of California-Berkeley, Berkeley, CA05/1994Preventive Medicine

    Collapse Overview 
    Collapse Overview
    My work focuses on environmental risk factors for Parkinson’s disease and other neurodegenerative disorders. Among these are pesticides, solvents, smoking and traumatic brain injury, the microbiome, and the interaction of these factors with genetic susceptibility factors.

    Collapse Research 
    Collapse Research Activities and Funding
    Integrating environmental, genomic, and functional data to characterize individual risk for Parkinson’s disease
    Department of Defense PD190037May 1, 2020 - Apr 30, 2023
    Role: PI
    Parkinson's Disease and Exposure to Chlorinated Solvents at Marine Base Camp Lejeune
    NIH I01CX002040Jan 1, 2020 - Sep 30, 2022
    Role: Principal Investigator
    Applying Artificial Intelligence for Early Identification of Parkinson's Disease
    Michael J. Fox Foundation P0543866Oct 1, 2019 - Sep 30, 2021
    Role: Co-PI
    Pediatric Environmental Health Specialty Unit, Western States
    ATSDR, American Academy of Pediatrics Sep 1, 2019 - Aug 31, 2023
    Role: PI
    Prevention of Hip Fractures in Patients with Parkinson?s Disease
    NIA P0524430Sep 1, 2018 - Aug 31, 2023
    Role: Co-Investigator
    Mitochondrial DNA damage in PD and control in a pesticide-exposed cohort
    Michael J. Fox Foundation A131409Jul 1, 2018 - Jun 30, 2020
    Role: PI
    Preventive Medicine Residencies
    Health Resources and Services Administration (HRSA) D33HP31668May 1, 2018 - Apr 30, 2023
    Role: Co-Investigator
    Heart rate variability as a biomarker of prodromal PD
    Michael J. Fox Foundation A127768Jul 1, 2016 - Dec 30, 2018
    Role: PI
    Parkinson's Disease Concordance and Heritability in the NAS/NRC World War II Veteran Twins Cohort
    University of California-San Francisco Resource Allocation Program 7504276Feb 1, 2016 - Feb 28, 2018
    Role: PI
    MtDNA Damage as a Biomarker for Environmental Mitochondrial Toxicity
    NIEHS R01 ES020718-04S1Aug 5, 2014 - May 31, 2017
    Role: PI
    Trichloroethylene and Parkinson's Disease
    NIH R21OH010372May 1, 2014 - Aug 31, 2017
    Role: PI
    Environmental Determinants of Expressivity and Penetrance in LRRK2 Parkinsonism
    Michael J. Fox Foundation Aug 1, 2013 - Jul 31, 2015
    Bay Area Solvents Study -Symptoms
    Michael J. Fox Foundation May 1, 2013 - Apr 30, 2015
    Role: Co-Investigator
    The Parkinson?'s Registry Investigation of Diagnosis and Etiology (PRIDE) Study
    Department of Defense W81XWH-13-1-0054Apr 1, 2013 - Mar 31, 2019
    Role: Co-PI
    Determinants of Penetrance & Expressivity of LRRK2 Mutations
    Brin Foundation May 1, 2009 - Apr 30, 2014
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective Investigation. Mov Disord. 2024 Feb 23. Dorsey ER, Kinel D, Pawlik ME, Zafar M, Lettenberger SE, Coffey M, Auinger P, Hylton KL, Shaw CW, Adams JL, Barbano R, Braun MK, Schwarz HB, Lawrence BP, Kieburtz K, Tanner CM, de Miranda BR, Goldman SM. PMID: 38389433.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Externally validated deep learning model to identify prodromal Parkinson's disease from electrocardiogram. Sci Rep. 2023 07 29; 13(1):12290. Karabayir I, Gunturkun F, Butler L, Goldman SM, Kamaleswaran R, Davis RL, Colletta K, Chinthala L, Jefferies JL, Bobay K, Ross GW, Petrovitch H, Masaki K, Tanner CM, Akbilgic O. PMID: 37516770; PMCID: PMC10387090.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune. JAMA Neurol. 2023 07 01; 80(7):673-681. Goldman SM, Weaver FM, Stroupe KT, Cao L, Gonzalez B, Colletta K, Brown EG, Tanner CM. PMID: 37184848; PMCID: PMC10186205.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    4. Early detection of Parkinson's disease through enriching the electronic health record using a biomedical knowledge graph. Front Med (Lausanne). 2023; 10:1081087. Soman K, Nelson CA, Cerono G, Goldman SM, Baranzini SE, Brown EG. PMID: 37250641; PMCID: PMC10217780.
      View in: PubMed   Mentions: 2  
    5. Trichloroethylene: An Invisible Cause of Parkinson's Disease? J Parkinsons Dis. 2023; 13(2):203-218. Dorsey ER, Zafar M, Lettenberger SE, Pawlik ME, Kinel D, Frissen M, Schneider RB, Kieburtz K, Tanner CM, De Miranda BR, Goldman SM, Bloem BR. PMID: 36938742; PMCID: PMC10041423.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    6. Enhancing Pandemic-Sensitive Recruitment Strategies for a Remote, Randomized Placebo-Controlled Trial for Fracture Prevention in Patients with Neurodegenerative Parkinsonisms (P1-1.Virtual). Neurology. 2022 May 3; 98(18_supplement). Luthra LN, Brown BE, Goldman GS, Zuzuarregui ZR, Hue HT, Schambach SC, Bledsoe BI, Schwarzschild SM, Dorsey DE, Espay EA, Litvan LI, McFarland MN, Mitchell MK, Standaert SD, Beck BJ, Rowbotham RH, Meng MC, Perkins PJ, Ranola RP, Picos PR, Kriesel KD, Lyles LK, Cummings CS, Tanner TC. .
      View in: Publisher Site   Mentions:
    7. Dry Cleaning & Parkinson’s Disease: Evaluation of a Potential Cluster (P11-11.001). Neurology. 2022 May 3; 98(18_supplement). Pawlik PM, Zafar ZM, Lettenberger LS, Coffey CM, Sarkar SA, Tanner TC, Goldman GS, De Miranda DB, Kieburtz KK, Kinel KD, Dorsey DE. .
      View in: Publisher Site   Mentions:
    8. Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables. J Parkinsons Dis. 2022; 12(1):341-351. Karabayir I, Butler L, Goldman SM, Kamaleswaran R, Gunturkun F, Davis RL, Ross GW, Petrovitch H, Masaki K, Tanner CM, Tsivgoulis G, Alexandrov AV, Chinthala LK, Akbilgic O. PMID: 34602502; PMCID: PMC8842767.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. Preventing Parkinson's Disease: An Environmental Agenda. J Parkinsons Dis. 2022; 12(1):45-68. De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER. PMID: 34719434; PMCID: PMC8842749.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    10. Remote smartphone monitoring of Parkinson's disease and individual response to therapy. Nat Biotechnol. 2022 04; 40(4):480-487. Omberg L, Chaibub Neto E, Perumal TM, Pratap A, Tediarjo A, Adams J, Bloem BR, Bot BM, Elson M, Goldman SM, Kellen MR, Kieburtz K, Klein A, Little MA, Schneider R, Suver C, Tarolli C, Tanner CM, Trister AD, Wilbanks J, Dorsey ER, Mangravite LM. PMID: 34373643.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    11. Short-term deceleration capacity of heart rate: a sensitive marker of cardiac autonomic dysfunction in idiopathic Parkinson's disease. Clin Auton Res. 2021 12; 31(6):729-736. Carricarte Naranjo C, Marras C, Visanji NP, Cornforth DJ, Sanchez-Rodriguez L, Schüle B, Goldman SM, Estévez M, Stein PK, Lang AE, Jelinek HF, Machado A. PMID: 34251546.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. NPJ Parkinsons Dis. 2021 Mar 01; 7(1):16. Tanner CM, Cummings SR, Schwarzschild MA, Brown EG, Dorsey ER, Espay AJ, Galifianakis NB, Goldman SM, Litvan I, Luthra N, McFarland NR, Mitchell KT, Standaert DG, Bauer DC, Greenspan SL, Beck JC, Lyles KW. PMID: 33649343; PMCID: PMC7921548.
      View in: PubMed   Mentions: 5  
    13. Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond. Neurotherapeutics. 2020 10; 17(4):1406-1417. Brown EG, Goldman SM. PMID: 33034846; PMCID: PMC7851230.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    14. Gradient boosting for Parkinson’s disease diagnosis from voice recordings. BMC Med Inform Decis Mak. 2020; 1(20):228-232. Karabayir I, Goldman SM, Pappu S, Akbilgic O.
    15. Gradient boosting for Parkinson's disease diagnosis from voice recordings. BMC Med Inform Decis Mak. 2020 09 15; 20(1):228. Karabayir I, Goldman SM, Pappu S, Akbilgic O. PMID: 32933493; PMCID: PMC7493334.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    16. Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance. Mov Disord. 2020 10; 35(10):1755-1764. San Luciano M, Tanner CM, Meng C, Marras C, Goldman SM, Lang AE, Tolosa E, Schüle B, Langston JW, Brice A, Corvol JC, Goldwurm S, Klein C, Brockman S, Berg D, Brockmann K, Ferreira JJ, Tazir M, Mellick GD, Sue CM, Hasegawa K, Tan EK, Bressman S, Saunders-Pullman R, Michael J. Fox Foundation LRRK2 Cohort Consortium. PMID: 32662532; PMCID: PMC7572560.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    17. Electrocardiographic changes predate Parkinson's disease onset. Sci Rep. 2020 07 09; 10(1):11319. Akbilgic O, Kamaleswaran R, Mohammed A, Ross GW, Masaki K, Petrovitch H, Tanner CM, Davis RL, Goldman SM. PMID: 32647196; PMCID: PMC7347531.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    18. Traumatic brain injury and α-synuclein: Proceed with caution. Neurology. 2020 02 25; 94(8):335-336. Brown EG, Goldman SM. PMID: 31992678.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. The Effect of the COVID-19 Pandemic on People with Parkinson's Disease. J Parkinsons Dis. 2020; 10(4):1365-1377. Brown EG, Chahine LM, Goldman SM, Korell M, Mann E, Kinel DR, Arnedo V, Marek KL, Tanner CM. PMID: 32925107; PMCID: PMC7683050.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansPHPublic Health
    20. Cervical dystonia incidence and diagnostic delay in a multiethnic population. Mov Disord. 2020 03; 35(3):450-456. LaHue SC, Albers K, Goldman S, Lo RY, Gu Z, Leimpeter A, Fross R, Comyns K, Marras C, de Kleijn A, Smit R, Katz M, Ozelius LJ, Bressman S, Saunders-Pullman R, Comella C, Klingman J, Nelson LM, Van Den Eeden SK, Tanner CM. PMID: 31774238; PMCID: PMC10683845.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    21. Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease. Clin Auton Res. 2019 12; 29(6):603-614. Carricarte Naranjo C, Marras C, Visanji NP, Cornforth DJ, Sanchez-Rodriguez L, Schüle B, Goldman SM, Estévez M, Stein PK, Lang AE, Jelinek HF, Machado A. PMID: 31444591.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    22. The NAS-NRC Twin Registry and Duke Twins Study of Memory in Aging: An Update. Twin Res Hum Genet. 2019 12; 22(6):757-760. Gatz M, Plassman BL, Tanner CM, Goldman SM, Swan GE, Chanti-Ketterl M, Walters EE, Butler DA. PMID: 31354124; PMCID: PMC7048234.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Rotenone and Parkinson's Disease: Reduced Sensitivity in Females. Toxicol Sci. 2019 06 01; 170(2):562-563. Goldman SM, Tanner CM. PMID: 31161209.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade. Mov Disord. 2019 06; 34(6):801-811. Marras C, Canning CG, Goldman SM. PMID: 31091353.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansPHPublic Health
    25. Concordance for Parkinson's disease in twins: A 20-year update. Ann Neurol. 2019 04; 85(4):600-605. Goldman SM, Marek K, Ottman R, Meng C, Comyns K, Chan P, Ma J, Marras C, Langston JW, Ross GW, Tanner CM. PMID: 30786044.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    26. Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson's disease in older men. Int J Epidemiol. 2018 10 01; 47(5):1679-1686. Leng Y, Goldman SM, Cawthon PM, Stone KL, Ancoli-Israel S, Yaffe K. PMID: 29873737; PMCID: PMC6208269.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    27. Mendel and urate: Acid test or random noise? Parkinsonism Relat Disord. 2018 08; 53:1-3. Brown EG, Goldman SM, Tanner CM. PMID: 30100365.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. The Microbiome in Neurodegenerative Disease. Current Geriatrics Reports. 2018 Jun 1; 7(2):81-91. Brown BE, Tanner TC, Goldman GS. .
      View in: Publisher Site   Mentions:
    29. 1018 Excessive Daytime Sleepiness, Objectively Measured Napping And 11-year Risk Of Parkinson’S Disease In Community-dwelling Older Men. Sleep. 2018 Apr 27; 41(suppl_1):a378-a378. Leng LY, Goldman GS, Cawthon CP, Stone SK, Ancoli-Israel AS, Yaffe YK. .
      View in: Publisher Site   Mentions:
    30. Heart Rate Variability (HRV) from a 10-second Electrocardiogram (ECG) in Parkinson’s Disease (PD) and Control (P1.037). Neurology. 2018 Apr 10; 90(15_supplement). Goldman GS, Kim KA, Meng MC, Comyns CK, Petrovitch PH, Tanner TC, Abbott AR, Ross RG. .
      View in: Publisher Site   Mentions:
    31. Advances in Neurotoxicology. Aschner M & Costa LG, eds. Pesticides and Parkinson's Disease: Current Experimental and Epidemiological Evidence. 2017; 1:83-118. Goldman SM, Musgrove RE, Jewell SA, Di Monte DA.
    32. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial. PLoS One. 2017; 12(2):e0169965. Ciesielska A, Samaranch L, San Sebastian W, Dickson DW, Goldman S, Forsayeth J, Bankiewicz KS. PMID: 28166239; PMCID: PMC5293261.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    33. Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease. Mov Disord. 2017 04; 32(4):610-614. Visanji NP, Bhudhikanok GS, Mestre TA, Ghate T, Udupa K, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Kim S, Azhu Valappil R, Kausar F, Rogaeva E, William Langston J, Tanner CM, Schüle B, Lang AE, Goldman SM, Marras C. PMID: 28071824.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    34. Chapter Three Pesticides and Parkinson's Disease: Current Experimental and Epidemiological Evidence. Environmental Factors in Neurodegenerative Diseases. 2017 Jan 1; 1:83-117. Goldman GS, Musgrove MR, Jewell JS, Di Monte DD. .
      View in: Publisher Site   Mentions:
    35. Blepharospasm in a Multiethnic Population (P3.348). Neurology. 2016 Apr 5; 86(16_supplement). Byrd BE, Albers AK, Goldman GS, Klingman KJ, Lo LR, Marras MC, Leimpeter LA, Fross FR, Comyns CK, Gu GZ, Katz KM, Ozelius OL, Bressman BS, Saunders-Pullman SR, Comella CC, Nelson NL, Van Den Eeden VS, Tanner TC. .
      View in: Publisher Site   Mentions:
    36. Polychlorinated Biphenyls (PCBs) and Parkinson's Disease (PD): Effect Modification by Membrane Transporter Variants (S32.004). Neurology. 2016 Apr 5; 86(16_supplement). Goldman GS, Kamel KF, Meng MC, Korell KM, Comyns CK, Umbach UD, Hoppin HJ, Ross RG, Marras MC, Kasten KM, Chade CA, Blair BA, Tanner TC. .
      View in: Publisher Site   Mentions:
    37. Prodromal Diagnoses in the Electronic Medical Record (EMR) Differ in Parkinson’s Disease (PD), Dementia with Lewy Bodies (DLB), Multiple System Atrophy (MSA), and Progressive Supranuclear Palsy (PSP) (P3.347). Neurology. 2016 Apr 5; 86(16_supplement). LaHue LS, Albers AK, Goldman GS, Leimpeter LA, Van Den Eeden VS, Tanner TC. .
      View in: Publisher Site   Mentions:
    38. Parkinson’s Disease and Movement Disorders. Jankovic J & Tolosa E, eds. Epidemiology of Parkinson’s Disease. 2016. Goldman, SM, Tanner, CM.
    39. A diagnostic algorithm for Parkinson's disease: what next? Lancet Neurol. 2015 Oct; 14(10):971-3. Goldman SM. PMID: 26271531.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Head injury, α-synuclein Rep1 and Parkinson's disease: a meta-analytic view of gene-environment interaction. Eur J Neurol. 2015 Jul; 22(7):e75. Goldman SM, Umbach DM, Kamel F, Tanner CM. PMID: 26060929.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    41. Cervical dystonia (CD) incidence and diagnostic delay in a multiethnic health maintenance organization. (S36.004). Neurology. 2015 Apr 6; 84(14_supplement). LaHue LS, Albers AK, Goldman GS, Klingman KJ, Lo LR, Marras MC, Leimpeter LA, Fross FR, Comyns CK, Gu GZ, Katz KM, Ozelius OL, Bressman BS, Saunders-Pullman SR, Comella CC, Nelson NL, Van Den Eeden VS, Tanner TC. .
      View in: Publisher Site   Mentions:
    42. Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol. 2015 Jun; 77(6):987-95. Gardner RC, Burke JF, Nettiksimmons J, Goldman S, Tanner CM, Yaffe K. PMID: 25726936; PMCID: PMC4447556.
      View in: PubMed   Mentions: 126     Fields:    Translation:Humans
    43. PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology. 2015 Mar 10; 84(10):972-80. Beecham GW, Dickson DW, Scott WK, Martin ER, Schellenberg G, Nuytemans K, Larson EB, Buxbaum JD, Trojanowski JQ, Van Deerlin VM, Hurtig HI, Mash DC, Beach TG, Troncoso JC, Pletnikova O, Frosch MP, Ghetti B, Foroud TM, Honig LS, Marder K, Vonsattel JP, Goldman SM, Vinters HV, Ross OA, Wszolek ZK, Wang L, Dykxhoorn DM, Pericak-Vance MA, Montine TJ, Leverenz JB, Dawson TM, Vance JM. PMID: 25663231; PMCID: PMC4352096.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    44. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 2015 Jan; 72(1):100-5. Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, Ruiz-Martínez J, Marti-Masso JF, Ferrer I, López de Munain A, Goldman SM, Schüle B, Langston JW, Aasly JO, Giordana MT, Bonifati V, Puschmann A, Canesi M, Pezzoli G, Maues De Paula A, Hasegawa K, Duyckaerts C, Brice A, Stoessl AJ, Marras C. PMID: 25401511; PMCID: PMC4399368.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansCells
    45. Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease. Environ Int. 2015 Feb; 75:144-50. Furlong M, Tanner CM, Goldman SM, Bhudhikanok GS, Blair A, Chade A, Comyns K, Hoppin JA, Kasten M, Korell M, Langston JW, Marras C, Meng C, Richards M, Ross GW, Umbach DM, Sandler DP, Kamel F. PMID: 25461423; PMCID: PMC4272866.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansPHPublic Health
    46. Protective Glove Use and Workplace Hygiene Practices Modify Associations between Pesticides and Parkinson's Disease. ISEE Conference Abstracts. 2014 Oct 20; 2014(1):1516. Furlong* FM, Tanner TC, Goldman GS, Bhudhikanok BG, Blair BA, Chade CA, Comyns CK, Korell KM, Hoppin HJ, Kasten KM, Langston LJ, Marras MC, Meng MC, Richards RM, Ross RG, Umbach UD, Sandler SD, Kamel KF. .
      View in: Publisher Site   Mentions:
    47. Trichloroethylene: Toxicity and Health Risks. Trichloroethylene, Role in Parkinson's Disease. Blossom SJ and Gilbert K (eds). 2014. Goldman SM, Whisnant-Cash S.
    48. The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk. Alzheimers Dement. 2014 Jun; 10(3 Suppl):S213-25. Tanner CM, Goldman SM, Ross GW, Grate SJ. PMID: 24924672.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsPHPublic Health
    49. Peptidoglycan recognition protein genes and risk of Parkinson's disease. Mov Disord. 2014 Aug; 29(9):1171-80. Goldman SM, Kamel F, Ross GW, Jewell SA, Marras C, Hoppin JA, Umbach DM, Bhudhikanok GS, Meng C, Korell M, Comyns K, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Sandler DP, Langston JW, Tanner CM. PMID: 24838182; PMCID: PMC4777298.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    50. Heart Rate Variability in LRRK2 Parkinson’s Disease (S37.004). Neurology. 2014 Apr 8; 82(10_supplement). Goldman GS, Schuele SB, Bhudhikanok BG, Cash CS, Korell KM, Amiri AY, Meng MC, Comyns CK, Guest GD, Rees RL, Kim KS, Kausar KF, Sundarrajan SS, Drabant Conley DE, Eriksson EN, Liang LG, Brandabur BM, Tetrud TJ, Langston LJ, Tanner TC. .
      View in: Publisher Site   Mentions:
    51. Role of Trichloroethylene in Parkinson’s Disease. Trichloroethylene: Toxicity and Health Risks. 2014 Jan 1; 91-129. Goldman GS, Cash CS. .
      View in: Publisher Site   Mentions:
    52. Dietary fat intake, pesticide use, and Parkinson's disease. Parkinsonism Relat Disord. 2014 Jan; 20(1):82-7. Kamel F, Goldman SM, Umbach DM, Chen H, Richardson G, Barber MR, Meng C, Marras C, Korell M, Kasten M, Hoppin JA, Comyns K, Chade A, Blair A, Bhudhikanok GS, Webster Ross G, William Langston J, Sandler DP, Tanner CM. PMID: 24120951; PMCID: PMC3936597.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    53. Environmental toxins and Parkinson's disease. Annu Rev Pharmacol Toxicol. 2014; 54:141-64. Goldman SM. PMID: 24050700.
      View in: PubMed   Mentions: 178     Fields:    Translation:HumansAnimalsPHPublic Health
    54. Parkinson's Disease. Effects of Persistent and Bioactive Organic Pollutants on Human Health. 2013 Aug 16; 471-513. Goldman GS. .
      View in: Publisher Site   Mentions:
    55. Incidence of Primary Torsion Dystonia in a Multiethnic Population (S53.001). Neurology. 2013 Feb 12; 80(7_supplement). Tanner TC, Albers AK, Goldman GS, Klingman KJ, Lo LR, Marras MC, Leimpeter LA, Fross FR, Gu GZ, Smit SR, de Kleijn dA, Bhudhikanok BG, Ozelius OL, Bressman BS, Saunders-Pullman SR, Comella CC, Nelson NL, Van Den Eeden VS. .
      View in: Publisher Site   Mentions:
    56. Parkinson's Disease Risk Is Associated with Variants in Genes That Bind Bacterial Cell-Wall Peptidoglycan (P05.051). Neurology. 2013 Feb 12; 80(7_supplement). Goldman GS, Jewell JS, Meng MC, Ross RW, Chade CA, Kasten KM, Bhudhikanok BG, Comyns CK, Korell KM, Langston LJ, Tanner TC. .
      View in: Publisher Site   Mentions:
    57. Industrial and Occupational Exposures and Parkinson Disease. Parkinson\u0027s Disease, Second Edition. 2012 Oct 9; 73-90. Pfeiffer PR, Wszolek WZ, Ebadi EM, Goldman GS. .
      View in: Publisher Site   Mentions:
    58. Genetic modification of the association of paraquat and Parkinson's disease. Mov Disord. 2012 Nov; 27(13):1652-8. Goldman SM, Kamel F, Ross GW, Bhudhikanok GS, Hoppin JA, Korell M, Marras C, Meng C, Umbach DM, Kasten M, Chade AR, Comyns K, Richards MB, Sandler DP, Blair A, Langston JW, Tanner CM. PMID: 23045187; PMCID: PMC3572192.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansPHPublic Health
    59. Reply. Annals of Neurology. 2012 Aug 1; 72(2):294-295. Goldman GS, Quinlan QP, Ross RG, Marras MC, Langston LJ, Tanner TC. .
      View in: Publisher Site   Mentions:
    60. Seborrheic Dermatitis and Risk of Future Parkinson's Disease (PD) (S42.001). Neurology. 2012 Apr 26; 78(Meeting Abstracts 1):s42.001-s42.001. Tanner TC, Albers AK, Goldman GS, Fross FR, Leimpeter LA, Klingman KJ, Van Den Eeden VS. .
      View in: Publisher Site   Mentions:
    61. Risk of Parkinson's Disease (PD) Associated with the Herbicide Paraquat Is Attenuated by High Dietary Intake of Polyunsaturated Fatty Acids (PUFAs) (S42.004). Neurology. 2012 Apr 26; 78(Meeting Abstracts 1):s42.004-s42.004. Kamel KF, Richardson RG, Umbach UD, Richards RM, Bhudhikanok BG, Blair BA, Chade CA, Comyns CK, Goldman GS, Hoppin HJ, Kasten KM, Korell KM, Marras MC, Meng MC, Ross RG, Langston LJ, Sandler SD, Tanner TC. .
      View in: Publisher Site   Mentions:
    62. Paraquat Use Modifies the Association of Head Injury and Parkinson's Disease (PD) (S42.003). Neurology. 2012 Apr 26; 78(Meeting Abstracts 1):s42.003-s42.003. Goldman GS, Kamel KF, Bhudhikanok BG, Korell KM, Meng MC, Comyns CK, Umbach UD, Hoppin HJ, Ross RW, Marras MC, Kasten KM, Chade CA, Sandler SD, Blair BA, Langston LJ, Tanner TC. .
      View in: Publisher Site   Mentions:
    63. Genetics meets environment: evaluating gene-environment interactions in neurologic diseases. Semin Neurol. 2011 Nov; 31(5):553-61. Marras C, Goldman SM. PMID: 22266892.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    64. Head injury, α-synuclein Rep1, and Parkinson's disease. Ann Neurol. 2012 Jan; 71(1):40-8. Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM. PMID: 22275250; PMCID: PMC3270814.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    65. 2.17.3 TRICHLOROETHYLENE (TCE) EXPOSURE AND PARKINSON'S DISEASE (PD) RISK. Parkinsonism & Related Disorders. 2012 Jan 1; 18:s89. Goldman GS. .
      View in: Publisher Site   Mentions:
    66. Solvent exposures and Parkinson disease risk in twins. Ann Neurol. 2012 Jun; 71(6):776-84. Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS, Comyns K, Korell M, Chade AR, Kasten M, Priestley B, Chou KL, Fernandez HH, Cambi F, Langston JW, Tanner CM. PMID: 22083847; PMCID: PMC3366287.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansPHPublic Health
    67. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet. 2011 Jun; 7(6):e1002141. Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston JW, Wojcicki A, Eriksson N. PMID: 21738487; PMCID: PMC3121750.
      View in: PubMed   Mentions: 281     Fields:    Translation:Humans
    68. Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect. 2011 Jun; 119(6):866-72. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DM, Blair A, Sandler DP, Langston JW. PMID: 21269927; PMCID: PMC3114824.
      View in: PubMed   Mentions: 498     Fields:    Translation:HumansCellsPHPublic Health
    69. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. Mov Disord. 2010 Oct 30; 25(14):2296-303. Valappil RA, Black JE, Broderick MJ, Carrillo O, Frenette E, Sullivan SS, Goldman SM, Tanner CM, Langston JW. PMID: 20976736.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    70. Trichloroethylene and Parkinson's disease: dissolving the puzzle. Expert Rev Neurother. 2010 Jun; 10(6):835-7. Goldman SM. PMID: 20518596.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    71. O.006 Epidemiology of dystonia. Parkinsonism & Related Disorders. 2009 Dec 1; 15:s2-s3. Goldman GS. .
      View in: Publisher Site   Mentions:
    72. Pesticide Exposure and Parkinson's Disease (PD) in the Agricultural Health Study (AHS). Epidemiology. 2009 Nov 1; 20(6):s244. Kamel KF, Bhudhikanok BG, Blair BA, Goldman GS, Hoppin HJ, Korell KM, Langston LJ, Richards RM, Ross RG, Sandler SD, Umbach UD, Tanner TC. .
      View in: Publisher Site   Mentions:
    73. Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ Health Perspect. 2009 Jan; 117(1):117-21. Bronstein J, Carvey P, Chen H, Cory-Slechta D, DiMonte D, Duda J, English P, Goldman S, Grate S, Hansen J, Hoppin J, Jewell S, Kamel F, Koroshetz W, Langston JW, Logroscino G, Nelson L, Ravina B, Rocca W, Ross GW, Schettler T, Schwarzschild M, Scott B, Seegal R, Singleton A, Steenland K, Tanner CM, Van Den Eeden S, Weisskopf M. PMID: 19165397; PMCID: PMC2627854.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    74. Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol. 2007 Feb 15; 165(4):364-74. Kamel F, Tanner C, Umbach D, Hoppin J, Alavanja M, Blair A, Comyns K, Goldman S, Korell M, Langston J, Ross G, Sandler D. PMID: 17116648.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansPHPublic Health
    75. Head injury and Parkinson's disease risk in twins. Ann Neurol. 2006 Jul; 60(1):65-72. Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW. PMID: 16718702.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    76. Occupation and parkinsonism in three movement disorders clinics. Neurology. 2005 Nov 08; 65(9):1430-5. Goldman SM, Tanner CM, Olanow CW, Watts RL, Field RD, Langston JW. PMID: 16162857.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansPHPublic Health
    77. Smell identification ability in twin pairs discordant for Parkinson's disease. Mov Disord. 2005 Jun; 20(6):687-93. Marras C, Goldman S, Smith A, Barney P, Aston D, Comyns K, Korell M, Langston JW, Ross GW, Tanner CM. PMID: 15719425.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    78. American College of Preventive Medicine practice policy statement: screening for Chlamydia trachomatis. Am J Prev Med. 2003 Apr; 24(3):287-92. Hollblad-Fadiman K, Goldman SM. PMID: 12657352.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    79. Smoking and Parkinson's disease in twins. Neurology. 2002 Feb 26; 58(4):581-8. Tanner CM, Goldman SM, Aston DA, Ottman R, Ellenberg J, Mayeux R, Langston JW. PMID: 11865136.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    80. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology. 2001 Oct 23; 57(8):1389-91. Tanner CM, Goldman SM, Lyons KE, Aston DA, Tetrud JW, Welsh MD, Langston JW, Koller WC. PMID: 11673577.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    81. Parkinson disease in twins: an etiologic study. JAMA. 1999 Jan 27; 281(4):341-6. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW. PMID: 9929087.
      View in: PubMed   Mentions: 192     Fields:    Translation:Humans
    82. Epidemiology of Tourette syndrome. Neurol Clin. 1997 May; 15(2):395-402. Tanner CM, Goldman SM. PMID: 9115469.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    83. Attitudes and educational practices of obstetric providers regarding infant hepatitis B vaccination. Obstet Gynecol. 1997 Jan; 89(1):61-4. Zola J, Smith N, Goldman S, Woodruff BA. PMID: 8990439.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    84. Epidemiology of Parkinson's disease. Neurol Clin. 1996 May; 14(2):317-35. Tanner CM, Goldman SM. PMID: 8827174; PMCID: PMC7173037.
      View in: PubMed   Mentions: 160     Fields:    Translation:HumansPHPublic Health
    85. Epidemiology of movement disorders. Curr Opin Neurol. 1994 Aug; 7(4):340-5. Tanner CM, Goldman SM. PMID: 7952243.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    86. Effects of renal clearance on plasma concentrations of homovanillic acid. Methodologic cautions. Arch Gen Psychiatry. 1989 Jun; 46(6):558-62. Potter WZ, Hsiao JK, Goldman SM. PMID: 2730280.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Samuel's Networks
    Concepts (226)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.